Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 33.68
-1.32 (-3.77%)
Sep 4, 2026, 4:29 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 46.42 million as of September 4, 2026. Its market cap has increased by 50.35% in one year.
Market Cap
46.42M
Enterprise Value
43.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
33.68
ChartMarket Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 46.42M, an increase of 433.94%. That is a compound annual growth rate of 8.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 46.42M | 124.14% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.37M |
| Bioventix | 90.13M |
| Faron Pharmaceuticals Oy | 80.14M |
| 4basebio | 73.81M |
| Poolbeg Pharma | 63.75M |
| Ondine Biomedical | 62.35M |
| hVIVO | 46.72M |
| Hemogenyx Pharmaceuticals | 38.42M |